CAS 1354787-69-1

DC41

CAS : 1354787-69-1

DC41 is an anticancer drug that works by inhibiting specific proteins involved in cancer cell growth and division. It is a potent inhibitor of cyclin-dependent kinases, which play a crucial role in regulating the cell cycle. DC41 has been shown to induce apoptosis (cell death) in tumor cells, making it a promising candidate for cancer treatment. This drug has also demonstrated efficacy against various types of cancer cells, including human and Chinese hamster ovary cells. DC41 analogs have been developed to improve its potency and selectivity as an inhibitor of protein kinases, making it a valuable tool for cancer research and drug development.

Formule : C₃₇H₃₄ClN₅O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 680.2 g/mol

Ref: 3D-EEC78769

DC41

CAS : 1354787-69-1

DC41 is a CC-1065-based cancer drug, an antibody-linked DNA alkylator.

Formule : C₃₇H₃₄ClN₅O₄S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 680.22

Ref: TM-T10974